Early rhythm control with ablation or antiarrhythmic drugs is associated with a lower risk of adverse cardiovascular outcomes compared with rate control in patients with newly diagnosed atrial ...

Initiation of rhythm control with antiarrhythmic drugs and/or ablation in patients with early, recently diagnosed atrial fibrillation led to a significantly lower risk for major adverse cardiovascular ...

Please provide your email address to receive an email when new articles are posted on . The benefits of early, systematic rhythm control therapy were consistent regardless of whether patients had ...

Although an early rhythm-control strategy outperformed a primarily rate-control approach for cardiovascular (CV) outcomes in patients with recent-onset atrial fibrillation (AF) in a recent trial, the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The EAST-AFNET 4 trial “clearly shows that early ...

(UPDATED) Swift initiation of rhythm-control therapy in patients with recently diagnosed atrial fibrillation in the setting of other cardiovascular conditions reduced the risk of CV events as compared ...

The management of patients with atrial fibrillation involves three main areas: anticoagulation, rate control and rhythm control. Importantly, these are not mutually exclusive of each other.

Most patients received flecainide, dronedarone, or amiodarone. At baseline, sinus rhythms were recorded more often in patients in the early rhythm control vs standard care group. Catheter ablation was ...

The choice of management strategy in patients with recent-onset AF does not affect clinical outcomes, but does influence the likelihood of progression to permanent AF, according to data from an ...

The analysis compared patients who received rhythm-control therapy for the treatment of new-onset AF to those who did not. Among critically ill patients with sustained new-onset atrial fibrillation ...

Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...